Duke Street: Inspiring the Ambitious

Healthcare / We are keen to invest in companies providing Healthcare Services to patients in the UK and France, but also look for opportunities to back producers of medical equipment and pharmaceuticals.

While the Healthcare Services sector presents some obvious risks and challenges, it is well suited to the Duke Street approach to company transformation. Many sectors are highly fragmented and ripe for consolidation – presenting huge scope for operational improvements and for organic and acquisition-led growth. In this context we are keen to back strong management teams to pursue these growth opportunities with a focus on quality and sector leadership.

We successfully demonstrated our approach with our investment in Paragon, the UK’s leading provider of care for residents with long-term learning difficulties. Currently we are backing two more management teams in this sector – Oasis, the UK dentistry group and Biomnis, the French specialist medical diagnostic company. Recent investments in this sector include Affinity Healthcare, a leading regional provider of psychiatric care services, and Groupe Proclif, our French private hospital group, which we grew from two to ten hospitals under our ownership.

Although most of our recent investments have been in healthcare services, we are also looking to invest in companies that manufacture and sell products, such as speciality pharmaceuticals, medical devices, backing strong management teams to pursue innovative growth strategies.